NCT00905541
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- University of Bonn Bonn, Germany
Clinical trial condition
Lipid Metabolism Disorders
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
3,309 public trials
330 recruiting studies
Lipid Metabolism Disorders trial results
NCT00326326
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Pfizer Investigational Site Anniston, Alabama, United States
- Pfizer Investigational Site Huntsville, Alabama, United States
- Pfizer Investigational Site Greenbrae, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
NCT00029835
- Conditions
- Body Weight, Dyslipidemia, Dyslipidemias, +9 more
- Locations
-
- Clinic of Physicians and Surgeons, LTD Mesa, Arizona, United States
- Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
- Irvine Center for Clinical Research (ICCR) Irvine, California, United States
- Los Angeles Clinical Trials Los Angeles, California, United States
NCT00200993
- Conditions
- Body Weight, Cardiovascular Diseases, Dyslipidemias, +17 more
- Locations
-
Not specified
NCT00688454
- Conditions
- Dyslipidemias, Hypercholesteremia, Hypercholesterolemia, +4 more
- Locations
-
Not specified
NCT00877825
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hyperlipidemia, +4 more
- Locations
-
Not specified
NCT00239967
- Conditions
- Body Weight, Dyslipidemia, Dyslipidemias, +9 more
- Locations
-
- Sanofi-aventis Administrative Office Bridgewater, New Jersey, United States
- Sanofi-aventis Administrative Office Macquarie Park, Australia
- Sanofi-aventis Administrative Office São Paulo, Brazil
- Sanofi-aventis Administrative Office Laval, Canada
NCT00653445
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +12 more
- Locations
-
Not specified
Completed
Rosuvastatin ORBITAL Germany
NCT00379249
- Conditions
- Behavior, Dyslipidemias, Health Behavior, +8 more
- Locations
-
Not specified
NCT00654446
- Conditions
- Dyslipidemias, Fredrickson Type IIa & Type IIb Dyslipidaemia, Lipid Metabolism Disorders, +2 more
- Locations
-
Not specified